Cargando…

Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome (PCOS) is associated with obesity and increased risk for type 2 diabetes (T2D). However, the prospective risk of T2D in normal weight women with PCOS is debated, together with the relevant prospective screening programs for T2D in normal weight women with PCOS....

Descripción completa

Detalles Bibliográficos
Autores principales:	Glintborg, Dorte, Kolster, Naja Due, Ravn, Pernille, Andersen, Marianne Skovsager
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220967/ https://www.ncbi.nlm.nih.gov/pubmed/35740476 http://dx.doi.org/10.3390/biomedicines10061455

Ejemplares similares

Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial
por: Ravn, Pernille, et al.
Publicado: (2022)

Diabetes Mellitus Mediates Risk of Depression in Danish Women with Polycystic Ovary Syndrome—A National Cohort Study
por: Glintborg, Dorte, et al.
Publicado: (2022)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2018)

Higher blood pressure in normal weight women with PCOS compared to controls
por: Mellembakken, Jan Roar, et al.
Publicado: (2021)

Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
por: Glintborg, Dorte, et al.
Publicado: (2019)

Accelerated osteoarthritis in women with polycystic ovary syndrome: a prospective nationwide registry-based cohort study
por: Kluzek, Stefan, et al.
Publicado: (2021)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Genetic Alterations within the DENND1A Gene in Patients with Polycystic Ovary Syndrome (PCOS)
por: Eriksen, Mette B., et al.
Publicado: (2013)

Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe
por: Piltonen, Terhi T., et al.
Publicado: (2019)

Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma
por: Hansen, Morten Steen Svarer, et al.
Publicado: (2017)

Recurrent autoimmune hypophysitis treated with rituximab: a case report
por: Kruse, Maria, et al.
Publicado: (2021)

Maternal Testosterone Concentrations in Third Trimester and Offspring Handgrip Strength at 5 Years: Odense Child Cohort
por: Dybdahl, Malene, et al.
Publicado: (2022)

Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS
por: Glintborg, Dorte, et al.
Publicado: (2018)

Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
por: Panico, Annalisa, et al.
Publicado: (2017)

Masculinising testosterone treatment and effects on preclinical cardiovascular disease, muscle strength and power, aggression, physical fitness and respiratory function in transgender men: protocol for a 10-year, prospective, observational cohort study in Denmark at the Body Identity Clinic (BIC)
por: Lehmann Christensen, Louise, et al.
Publicado: (2020)

Visfatin and Resistin Serum Levels in Normal-Weight and Obese Women With Polycystic Ovary Syndrome
por: Farshchian, Fatemeh, et al.
Publicado: (2014)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women
por: Li, Shuxia, et al.
Publicado: (2016)

Testosterone therapy increases the anticoagulant potential in men with opioid-induced hypogonadism: a randomized, placebo-controlled study
por: Bøgehave, Mette, et al.
Publicado: (2023)

Lower Fiber Consumption in Women with Polycystic Ovary Syndrome: A Meta-Analysis of Observational Studies
por: Leung, Wing Ting, et al.
Publicado: (2022)

Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome
por: Dumesic, Daniel A, et al.
Publicado: (2023)

Heart rate variability in normal-weight patients with polycystic ovary syndrome
por: Kilit, Celal, et al.
Publicado: (2017)

Heart rate variability in normal-weight patients with polycystic ovary syndrome
por: Perini, Renza
Publicado: (2017)

Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome
por: Skov, Vibe, et al.
Publicado: (2008)

Gender affirming hormonal treatment in Danish transgender persons: A nationwide register‐based study
por: Glintborg, Dorte, et al.
Publicado: (2022)

Heavy Metals and Essential Elements in Association with Oxidative Stress in Women with Polycystic Ovary Syndrome—A Systematic Review
por: Srnovršnik, Tinkara, et al.
Publicado: (2023)

Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women
por: Dumesic, Daniel A, et al.
Publicado: (2021)

Depression in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Dybciak, Paweł, et al.
Publicado: (2023)

Endoscopic vs. microscopic transsphenoidal pituitary surgery: a single centre study
por: Møller, Morten Winkler, et al.
Publicado: (2020)

Serum C-Reactive Protein Levels in Normal-Weight Polycystic Ovary Syndrome
por: Oh, Ji Young, et al.
Publicado: (2009)

Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
por: Yasmin, Afrin, et al.
Publicado: (2022)

Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome
por: Gholinezhad, Maryam, et al.
Publicado: (2018)

Health-related quality of life in polycystic ovary syndrome patients: A systematic review
por: Taghavi, Seyed Abdolvahab, et al.
Publicado: (2015)

Medical and Surgical Treatment of Reproductive Outcomes in Polycystic Ovary Syndrome: An Overview of Systematic Reviews
por: Gadalla, Moustafa A., et al.
Publicado: (2020)

Polycystic Ovary Syndrome and Endocrine Disruptors (Bisphenols, Parabens, and Triclosan)—A Systematic Review
por: Srnovršnik, Tinkara, et al.
Publicado: (2023)

Socioeconomic status in Danish transgender persons: a nationwide register-based cohort study
por: Glintborg, Dorte, et al.
Publicado: (2021)

Polycystic Ovary Syndrome Triggers Atrial Conduction Disorders: A Systematic Review and Meta-Analysis
por: Moysidis, Dimitrios V., et al.
Publicado: (2022)

Efficacy of Flavonoids on Animal Models of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Zhang, Jiacheng, et al.
Publicado: (2022)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q2v9i0cunt34fkc9133ejcjt2b